{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:02:28Z","timestamp":1768568548912,"version":"3.49.0"},"posted":{"date-parts":[[2024,4,19]]},"group-title":"Gastroenterology","reference-count":42,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,19]]},"abstract":"Abstract<\/jats:title>\n \n Objective<\/jats:title>\n Sphincter of Oddi Disorders (SOD) are contentious conditions in patients whose abdominal pain, idiopathic acute pancreatitis (iAP) might arise from pressurization at the sphincter of Oddi. The present study aimed to measure the benefit of sphincterotomy for suspected SOD.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Prospective cohort conducted at 14 U.S. centers with 12 months follow-up. Patients undergoing first-time ERCP with sphincterotomy for suspected SOD were eligible: pancreatobiliary-type pain with or without iAP. The primary outcome was defined as the composite of improvement by Patient Global Impression of Change (PGIC), no new or increased opioids, and no repeat intervention. Missing data were addressed by hierarchal, multiple imputation scheme.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 316 screened, 213 were enrolled with 190 (89.2%) of these having a dilated bile duct, abnormal labs, iAP, or some combination. By imputation, an average of 122\/213 (57.4% [95%CI 50.4-64.4]) improved; response rate was similar for those with complete follow-up (99\/161, 61.5%, [54.0-69.0]); of these, 118 (73.3%) improved by PGIC alone. Duct size, elevated labs, and patient characteristics were not associated with response. AP occurred in 37\/213 (17.4%) at a median of 6 months post-ERCP and was more likely in those with a history of AP (30.9 vs. 2.9%, p<0.0001).<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Nearly 60% of patients undergoing ERCP for suspected SOD improve, although the contribution of a placebo response is unknown. Contrary to prevailing belief, duct size and labs are poor response predictors. AP recurrence was common and like observations from prior non-intervention cohorts, suggesting no benefit of sphincterotomy in mitigating future AP episodes.<\/jats:p>\n \n \n Key Messages<\/jats:title>\n \n WHAT IS ALREADY KNOWN ON THIS TOPIC<\/jats:title>\n \n \n It is not clear if the sphincter of Oddi can cause abdominal pain (Functional Biliary Sphincter of Oddi Disorder) and idiopathic acute pancreatitis (Functional Pancreatic Sphincter of Oddi Disorder), and whether ERCP with sphincterotomy can ameliorate abdominal pain or pancreatitis.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>\n \n WHAT THIS STUDY ADDS<\/jats:title>\n \n \n Using multiple patient-reported outcome measures, most patients with suspected sphincter of Oddi disorder improve after ERCP with sphincterotomy.<\/jats:p>\n <\/jats:list-item>\n \n Duct size, elevated pancreatobiliary labs, and baseline patient characteristics are not independently associated with response.<\/jats:p>\n <\/jats:list-item>\n \n There is a high rate of recurrent acute pancreatitis within 12 months of sphincterotomy in those with a history of idiopathic acute pancreatitis.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>\n \n HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE, OR POLICY<\/jats:title>\n \n \n Since a discrete population with a high (> 80-90%) response rate to sphincterotomy for suspected pancreatobiliary pain could not be identified, there is a need for additional observational and interventional studies that include phenotyping of patients using novel imaging or biochemical biomarkers.<\/jats:p>\n <\/jats:list-item>\n \n There remains a pressing need for quantitative nociceptive biomarkers to distinguish pancreatobiliary pain from other causes of abdominal pain or central sensitization.<\/jats:p>\n <\/jats:list-item>\n \n Discovery of blood-, bile-, or imaging-based biomarkers for occult microlithiasis and pancreatitis may be helpful in predicting who is likely to benefit from sphincterotomy.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>\n <\/jats:sec>\n <\/jats:boxed-text>\n <\/jats:sec>","DOI":"10.1101\/2024.04.18.24305985","type":"posted-content","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:35:18Z","timestamp":1713555318000},"source":"Crossref","is-referenced-by-count":0,"title":["Sphincterotomy for Biliary Sphincter of Oddi Disorder and idiopathic Acute Recurrent Pancreatitis: THE RESPOND LONGITUDINAL COHORT"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-9302","authenticated-orcid":false,"given":"Gregory A.","family":"Cot\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Joseph","family":"Elmunzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Nitchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Field F.","family":"Willingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Wani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabh","family":"Chak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Slivka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Jamidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Tarnasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Varadarajulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia D.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024042308150808000_2024.04.18.24305985v1.1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1053\/j.gastro.2016.02.033","article-title":"Gallbladder and Sphincter of Oddi Disorders","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"2024042308150808000_2024.04.18.24305985v1.2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1053\/j.gastro.2023.02.033","article-title":"Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups","volume":"164","year":"2023","journal-title":"Gastroenterology"},{"key":"2024042308150808000_2024.04.18.24305985v1.3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/jama.2014.5220","article-title":"Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"2024042308150808000_2024.04.18.24305985v1.4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2012.09.006","article-title":"Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"2024042308150808000_2024.04.18.24305985v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.1.98"},{"key":"2024042308150808000_2024.04.18.24305985v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901123200203"},{"key":"2024042308150808000_2024.04.18.24305985v1.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.063"},{"key":"2024042308150808000_2024.04.18.24305985v1.8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2468-1253(18)30211-5","article-title":"Idiopathic recurrent acute pancreatitis","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024042308150808000_2024.04.18.24305985v1.9","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i12.1289"},{"key":"2024042308150808000_2024.04.18.24305985v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3"},{"key":"2024042308150808000_2024.04.18.24305985v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24725"},{"key":"2024042308150808000_2024.04.18.24305985v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07486.x"},{"key":"2024042308150808000_2024.04.18.24305985v1.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00341.x"},{"key":"2024042308150808000_2024.04.18.24305985v1.14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(23)02356-5","article-title":"Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"2024042308150808000_2024.04.18.24305985v1.15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5056\/jnm15123","article-title":"Sphincter of Oddi Manometry: Reproducibility of Measurements and Effect of Sphincterotomy in the EPISOD Study","volume":"22","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"2024042308150808000_2024.04.18.24305985v1.16","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/j.cgh.2021.03.008","article-title":"Characteristics of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Sphincter of Oddi Disorders","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024042308150808000_2024.04.18.24305985v1.17","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.3748\/wjg.v16.i35.4416","article-title":"Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction","volume":"16","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2024042308150808000_2024.04.18.24305985v1.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-018-1842-3"},{"key":"2024042308150808000_2024.04.18.24305985v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302779"},{"key":"2024042308150808000_2024.04.18.24305985v1.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15281"},{"key":"2024042308150808000_2024.04.18.24305985v1.21","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1016\/j.cgh.2020.11.008","article-title":"The Next EPISOD: Trends in Utilization of Endoscopic Sphincterotomy for Sphincter of Oddi Dysfunction from 2010-2019","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024042308150808000_2024.04.18.24305985v1.22","doi-asserted-by":"crossref","first-page":"E941","DOI":"10.1055\/s-0042-110789","article-title":"Wide disparities in attitudes and practices regarding Type II sphincter of Oddi dysfunction: a survey of expert U","volume":"4","year":"2016","journal-title":"S. endoscopists. Endosc Int Open"},{"key":"2024042308150808000_2024.04.18.24305985v1.23","doi-asserted-by":"crossref","unstructured":"Thiruvengadam NR , Saumoy M , Schaubel DE , et al. Rise In First-Time ERCP For Benign Indications >1 Year After Cholecystectomy Is Associated With Worse Outcomes. Clin Gastroenterol Hepatol 2024.","DOI":"10.1016\/j.cgh.2024.03.027"},{"key":"2024042308150808000_2024.04.18.24305985v1.24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bjs.1800540708","article-title":"The sites to which pain is referred from the common bile-duct in man and its implication for the theory of referred pain","volume":"54","year":"1967","journal-title":"Br J Surg"},{"key":"2024042308150808000_2024.04.18.24305985v1.25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.8.783"},{"key":"2024042308150808000_2024.04.18.24305985v1.26","first-page":"573","article-title":"A comparison of pain produced experimentally in lower esophagus, common bile duct, and upper small intestine with pain experienced by patients with diseases of biliary tract and pancreas","volume":"89","year":"1949","journal-title":"Surg Gynecol Obstet"},{"key":"2024042308150808000_2024.04.18.24305985v1.27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpsychores.2015.01.003","article-title":"The common link between functional somatic syndromes may be central sensitisation","volume":"78","year":"2015","journal-title":"J Psychosom Res"},{"key":"2024042308150808000_2024.04.18.24305985v1.28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/2192568219861972","article-title":"The Art of Surgery: The Strange World of the Placebo Response","volume":"9","year":"2019","journal-title":"Global Spine J"},{"key":"2024042308150808000_2024.04.18.24305985v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.03.023"},{"key":"2024042308150808000_2024.04.18.24305985v1.30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jclinepi.2016.12.010","article-title":"Sham surgical procedures for pain intervention result in significant improvements in pain: systematic review and meta-analysis","volume":"83","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2024042308150808000_2024.04.18.24305985v1.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009655"},{"key":"2024042308150808000_2024.04.18.24305985v1.32","doi-asserted-by":"crossref","unstructured":"Hart PA , Osypchuk Y , Hovbakh I , et al. A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study. Gastroenterology 2023.","DOI":"10.1053\/j.gastro.2023.12.008"},{"key":"2024042308150808000_2024.04.18.24305985v1.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.20967"},{"key":"2024042308150808000_2024.04.18.24305985v1.34","doi-asserted-by":"crossref","unstructured":"Rossettini G , Campaci F , Bialosky J , et al. The Biology of Placebo and Nocebo Effects on Experimental and Chronic Pain: State of the Art. J Clin Med 2023;12.","DOI":"10.3390\/jcm12124113"},{"key":"2024042308150808000_2024.04.18.24305985v1.35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.14309\/ajg.0000000000002097","article-title":"Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials","volume":"118","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2024042308150808000_2024.04.18.24305985v1.36","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225584.40212.fb"},{"key":"2024042308150808000_2024.04.18.24305985v1.37","doi-asserted-by":"crossref","unstructured":"Keyes KM , Rutherford C , Hamilton A , et al. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep 2022;3.","DOI":"10.1016\/j.dadr.2022.100052"},{"key":"2024042308150808000_2024.04.18.24305985v1.38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/jgh.16264","article-title":"The risk of recurrent pancreatitis after first episode of acute pancreatitis in relation to etiology and severity of disease: A systematic review, meta-analysis and meta-regression analysis","volume":"38","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"2024042308150808000_2024.04.18.24305985v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.405"},{"key":"2024042308150808000_2024.04.18.24305985v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.126"},{"key":"2024042308150808000_2024.04.18.24305985v1.41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cgh.2015.12.040","article-title":"Risk of Recurrent Pancreatitis and Progression to Chronic Pancreatitis After a First Episode of Acute Pancreatitis","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024042308150808000_2024.04.18.24305985v1.42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.pan.2016.07.009","article-title":"Endoscopic sphincterotomy (ES) may not alter the natural history of idiopathic recurrent acute pancreatitis (IRAP)","volume":"16","year":"2016","journal-title":"Pancreatology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.04.18.24305985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:58:41Z","timestamp":1768507121000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.04.18.24305985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1101\/2024.04.18.24305985","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1136\/gutjnl-2024-332686","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,4,19]]},"subtype":"preprint"}}